Skip to content
← Back to this collection

PUBLICATIONS · 17971587

Assessment of response to induction therapy and its influence on 5-year failure-free survival in group III rhabdomyosarcoma: the Intergroup Rhabdomyosarcoma Study-IV experience--a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2007 Nov 1
First author
Burke M

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Burke M
      type
      Author
    2. name
      Anderson JR
      type
      Author
    3. name
      Kao SC
      type
      Author
    4. name
      Rodeberg D
      type
      Author
    5. name
      Qualman SJ
      type
      Author
    6. name
      Wolden SL
      type
      Author
    7. name
      Meyer WH
      type
      Author
    8. name
      Breitfeld PP
      type
      Author
    9. name
      Soft Tissue Sarcoma Committee of the Children's Oncology Group
      type
      CollectiveName
    Complete bibliographic record and source provenance
    authors
    1. name
      Burke M
      type
      Author
    2. name
      Anderson JR
      type
      Author
    3. name
      Kao SC
      type
      Author
    4. name
      Rodeberg D
      type
      Author
    5. name
      Qualman SJ
      type
      Author
    6. name
      Wolden SL
      type
      Author
    7. name
      Meyer WH
      type
      Author
    8. name
      Breitfeld PP
      type
      Author
    9. name
      Soft Tissue Sarcoma Committee of the Children's Oncology Group
      type
      CollectiveName
    bibliography ids
    1. nci-bib-3e60afc39fbac23c0ebedfe4
    book metadata
    content sha256
    23a1c54ab7752975fdc1ea105cb1ecefff2767a8a8815afdcc27f7200aefd68b
    document type
    citation
    dois
    1. 10.1200/JCO.2006.10.4257
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:17971587
    immutable id
    pubmed:17971587@23a1c54ab7752975fdc1ea105cb1ecefff2767a8a8815afdcc27f7200aefd68b
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    31
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    4909-13
    volume
    25
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      17971587
      provenance
      batch id
      89a0f2206e11ca092d02
      provider
      NCBI PubMed ESummary
      record sha256
      9f46349d3e14197d58ab954dbbe584473294c0a55a587240fde5c9d8a0c01110
      response sha256
      7b1c355120884a7a596bcf7b4a243dc12308b7f7f0914c3fc71b0c8e8d79c708
      retrieved at
      2026-09-09T23:46:16.784581+00:00
      publication date
      display
      2007 Nov 1
      precision
      day
      year
      2007
      publication types
      1. Journal Article
      2. Randomized Controlled Trial
      3. Research Support, N.I.H., Extramural
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/17971587/
      title
      Assessment of response to induction therapy and its influence on 5-year failure-free survival in group III rhabdomyosarcoma: the Intergroup Rhabdomyosarcoma Study-IV experience--a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group.

      Preserved source evidence · Not medical advice